Point of Care
World's First Breathalyzer to Detect Infectious Diseases
Noze, an AI startup that has developed a technology to digitize the sense of smell, is building a breathalyzer, powered by its platform, to detect breath biomarkers (VOCs). This will allow for the rapid screening and diagnostics of infectious diseases like malaria and tuberculosis which are highly prevalent, especially in developing countries. More...16 Mar 2023
Novel Non-Sputum Based Technology Quickly and Easily Detects Active TB
Despite advancements in rapid molecular diagnostic techniques for tuberculosis (TB), there remains a significant need for a time-efficient, cost-effective, and non-sputum-based point-of-care (POC) test. Now, researchers at Wayne State University have discovered a new technology that can rapidly and easily detect active TB infection antibodies. More...16 Mar 2023
Rapid PCR Diagnostic Test for STIs Provides Accurate Results in Less than 30 Minutes at POC
A fast, polymerase chain reaction (PCR) diagnostic test rapidly tests for these three most common sexually transmitted infections (STIs) caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis, allowing healthcare professionals to test, talk and treat patients in a single visit. More...15 Mar 2023
First Commercially Available Lab-Based Blood Test to Help Evaluate Concussion
Abbott Diagnostics has received U.S. Food and Drug Administration clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test, making it widely available to hospitals in the U.S. More...08 Mar 2023
Compact POCT Platform Unlocks Multiplexing Potential of Real-Time PCR
A new real-time PCR platform aims to disrupt the molecular diagnostics status quo by bringing revolutionary lab-grade PCR testing capabilities - the gold standard in infectious disease testing -into homes and businesses. More...24 Feb 2023
New Diagnostic Test 1,000 Times More Sensitive than Conventional Tests
In their effort to overcome the limitations of point-of-care diagnostic tests, researchers have now developed ultrabright fluorescent nanolabels called plasmonic-fluors, which can be quickly integrated into the lateral flow assay (LFA), a common testing platform. Plasmon-enhanced LFAs (p-LFAs) improve inexpensive, readily available rapid tests to the levels of sensitivity required by physicians for confidence in test results without the need for lab-based confirmation. More...13 Feb 2023
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hypodermic Syringe
SurTract™ Safety Syringe
Patient Monitoring System
AlarmSense
In Other News
Portable, Low-Dose Medical Imaging System Delivers Fast 3D X-Ray Imaging at POC
Low-Cost Portable Sensor Detects Heavy Metals in Sweat
Liquid-Ready QC Solution for POC Urinalysis Instruments Helps Labs Streamline Daily Operations
FDA Cleared Sepsis Test Becomes First in New Class of ED-Focused Diagnostic Tools
Multi-Disease POC Breathalyzer Sniffs Out Infections and Monitors Patients on Ventilator
Rapid Diagnostic Platform Delivers Up To 30 Results from Single Drop of Body Fluid within 15 Minutes
World’s Most Child-Friendly Respiratory Swab Addresses Major Challenge of Testing Reluctance
POC Test Detects and Differentiates Between Upper Respiratory Infections Caused by Influenza and SARS-CoV-2
Advanced Hematology Analyzer Brings Simplicity and Efficiency to Decentralized Healthcare Facilities
Blood Test to Separate Bacterial and Viral Infections Could Reduce Antibiotic Overuse
Extremely Sensitive Fluorescence Lateral Flow Reader Detects Even Low Positives Results
POC Assay Could Diagnose Acute Coronary Syndrome in 3-5 Minutes
New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
POC Molecular TB Test Could Enable Clinicians to Begin Appropriate Treatment Immediately
Early Sepsis Recognition Platform Could Identify Pre-Symptomatic Patients at POC Using Culture-Free Diagnostic Test
New Digital Platform Technology Aims to Disrupt 50-Year-Old PCR Testing for Similar-Symptom Pathogens
Hand-Held POC Biosensor Quickly and Accurately Detects Oral Cancer
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
Rapid Credit Card-Sized UTI Diagnostic Test Detects Four Major Uropathogens from Urine Drop
Novel POC Hemolysis System Improves Patient Care, Reduces Workload for Emergency Departments and ICUs
Portable qPCR Platform Enables Faster, Better, Low-Cost Near-Patient Molecular Diagnosis
Portable UTI Molecular Diagnostic Platform Provides Accurate Test Results in 40 Minutes
New Wearable Patient Monitoring System Refines Clinician’s Workflow to Track Patient Conditions
The HospiMedica Point-of-Care Testing channel provides reporting on clinical/medical testing that is performed at the patient's side, near the patient and outside of the clinical laboratory. This would include testing provided by healthcare professionals and remote/field personnel and does not require processing by a central laboratory.